Riskpilot← Back to searchSign inGet full accessAndreas homeopat AB
ABActiveOrg 5593644353Knut Påls Väg 8Support activities for animal production · NACE 0162Est. 20221 employees
Revenue 2025
SEK 2,6M
+4% vs 2024
EBITDA margin
27.6%
-57% vs 2024
Equity ratio
65.6%
Financial strength
Net profit 2025
SEK 386K
-70% vs 2024
| Revenue | SEK 2,6M | +4% |
| EBITDA | SEK 728K | -57% |
| Net profit | SEK 386K | -70% |
| Total assets | SEK 2M | -23% |
| Equity | SEK 1,3M | -27% |
| Employees | 1 | — |
Legal name
Andreas homeopat AB
Org number
5593644353
Legal form
Aktiebolag
NACE code
0162 · Support activities for animal production
Founded
7 februari 2022
Share capital
SEK 25 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Föremålet för bolagets verksamhet skall vara att bedriva naturmedicinsk mottagning med verksamhet inom homeopati, kiropraktik och irisdiagnostik för människor och djur samt bedriva travträning för hästar samt verksamhet inom områdena travsport och hästdressyr även uthyrning av personal inom transport samt åkeriverksamhet med tunga fordon och därmed jämförlig verksamhet.
Address
Knut Påls Väg 8
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | 1 297 | 2 530 | 2 634 |
| Staff expenses | — | — | — |
| EBITDA | 1 045 | 1 677 | 728 |
| Depreciation & amort. | −4 | −51 | −215 |
| EBIT | 1 041 | 1 626 | 513 |
| Net financials | — | 1 | −23 |
| Profit before tax | 790 | 1 626 | 490 |
| Tax | −163 | −336 | −104 |
| Net profit | 627 | 1 290 | 386 |
| Item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Total assets | 1 063 | 2 528 | 1 954 |
| Equity | 652 | 1 747 | 1 282 |
| Long-term debt | 0 | 0 | 0 |
| Short-term debt | 160 | 531 | 422 |
| Total debt | 160 | 531 | 422 |
EBITDA margin
27.6%
This company
15.8%
Market median
+75% vs market
20232025
Equity ratio
65.6%
This company
38.2%
Market median
+72% vs market
20232025
Return on equity
30.1%
This company
18.4%
Market median
+64% vs market
20232025
Net profit margin
14.7%
This company
8.1%
Market median
+81% vs market
20232025
Asset turnover
1.35×
This company
1.12×
Market median
+21% vs market
20232025
Debt / equity
0.52×
This company
0.62×
Market median
+16% vs market
20232025
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
| Former (2) | ||
| Deputy Board Member | 2022 – 2022 | |
| Board of Directors | 2022 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Andreas homeopat AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Per Daniel Englund Rydberg | Deputy Board Member | 0 companies |
| Tom Nikolaus Thorén | Board of Directors | 0 companies |
| Nina Elisabet Fajersson | Deputy Board Member | 0 companies |
| Andreas Hermann Kalderon | Board of Directors | 0 companies |